Vystar Corporation announced a strategic move into the film industry through its 50% stake in R3ALM, which offers technology and services to engage movie audiences beyond ticket sales. This includes merchandise, fan clubs, memorabilia, events, and digital tokens like the FSMT Bloodline Killers 2 token, which has seen significant market interest. Unlike traditional movie investments, Vystar focuses on building ongoing commercial relationships around films, leveraging digital finance and tokenization to create new revenue streams. The company aims to expand this model across multiple productions, offering investors a public-market opportunity in this evolving entertainment ecosystem.
Vystar Corporation's film industry move is context for readers. For those tracking Media-sector US stocks on Pluang, 21 out of 57 rose and 32 fell as of Nov 12, 2026 19:11 WIB. Notable prices include SKM at USD 33.99 with a -1.05% change, TKO at USD 201.59 up 1.05%, and NRDS at USD 7.78 up 1.04%, with NRDS showing 17% sell and 83% buy order activity and a typical hold time of 44 days.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
